---
title: "NEPG subsidiary obtains drug registration certificate for Levetiracetam extended-release tablets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235178199.md"
description: "NEPG's wholly-owned subsidiary has obtained the drug registration certificate for Levetiracetam Extended-Release Tablets, suitable for adjunctive treatment of partial seizures in patients aged 12 and above. This registration certificate will enrich the company's product line, enhance market competitiveness, and create new market opportunities"
datetime: "2025-04-09T08:58:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235178199.md)
  - [en](https://longbridge.com/en/news/235178199.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235178199.md)
---

# NEPG subsidiary obtains drug registration certificate for Levetiracetam extended-release tablets

According to the Zhitong Finance APP, Northeast Pharmaceutical (000597.SZ) announced that its wholly-owned subsidiary, Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration, involving the product: Levetiracetam Extended-Release Tablets. Levetiracetam Extended-Release Tablets are used as an adjunctive treatment for partial seizures in patients aged 12 and older with epilepsy.

The acquisition of the "Drug Registration Certificate" for Levetiracetam Extended-Release Tablets is beneficial for further enriching the company's product pipeline, enhancing the company's market competitiveness, and bringing new market opportunities

### Related Stocks

- [000597.CN](https://longbridge.com/en/quote/000597.CN.md)

## Related News & Research

- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Grown Up Group Sets June 2026 AGM to Approve Results and Share Mandate](https://longbridge.com/en/news/286990715.md)
- [Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M](https://longbridge.com/en/news/287282241.md)
- [13:53 ETHouston-Based Founder Dr. Bre Hayward Expands Multicultural Haircare Brand "Baby Hair®" Under Phase Theory Beauty Co™](https://longbridge.com/en/news/287258308.md)
- [15:15 ETGreenberg Traurig Strengthens SALT Practice with John Ormonde in Washington, D.C.](https://longbridge.com/en/news/287263362.md)